Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort

Abstract

Objective:

Studies have shown that common single-nucleotide polymorphisms (SNPs) in the serotonin 5-HT-2C receptor (HTR2C) are associated with antipsychotic agent-induced weight gain and the development of behavioural and psychological symptoms. We aimed to analyse whether variation in the HTR2C is associated with obesity- and mental health-related phenotypes in a large population-based cohort.

Method:

Six tagSNPs, which capture all common genetic variation in the HTR2C gene, were genotyped in 4978 men and women from the European Prospective Investigation into Cancer (EPIC)–Norfolk study, an ongoing prospective population-based cohort study in the United Kingdom. To confirm borderline significant associations, the −759C/T SNP (rs3813929) was genotyped in the remaining 16 003 individuals from the EPIC–Norfolk study. We assessed social and psychological circumstances using the Health and Life Experiences Questionnaire. Genmod models were used to test associations between the SNPs and the outcomes. Logistic regression was performed to test for association of SNPs with obesity- and mental health- related phenotypes.

Results:

Of the six HTR2C SNPs, only the T allele of the –759C/T SNP showed borderline significant associations with higher body mass index (BMI) (0.23 kg m–2; (95% confidence interval (CI): 0.01–0.44); P=0.051) and increased risk of lifetime major depressive disorder (MDD) (Odds ratio (OR): 1.13 (95% CI: 1.01–1.22), P=0.02). The associations between the −759C/T and BMI and lifetime MDD were independent. As associations only achieved borderline significance, we aimed to validate our findings on the –759C/T SNP in the full EPIC–Norfolk cohort (n=20 981). Although the association with BMI remained borderline significant (β=0.20 kg m–2; 95% CI: 0.04–0.44, P=0.09), that with lifetime MDD (OR: 1.01; 95% CI: 0.94–1.09, P=0.73) was not replicated.

Conclusions:

Our findings suggest that common HTR2C gene variants are unlikely to have a major role in obesity- and mental health-related traits in the general population.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Lucki I . The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151–162.

    Article  CAS  Google Scholar 

  2. Drago A, Serretti A . Focus on HTR2C: a possible suggestion for genetic studies of complex disorders. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 601–637.

    Article  CAS  Google Scholar 

  3. Rocha BA, Goulding EH, O’Dell LE, Mead AN, Coufal NG, Parsons LH et al. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 2002; 22: 10039–10045.

    Article  CAS  Google Scholar 

  4. Nonogaki K, Abdallah L, Goulding EH, Bonasera SJ, Tecott LH . Hyper-activity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes 2003; 52: 315–320.

    Article  CAS  Google Scholar 

  5. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542–546.

    Article  CAS  Google Scholar 

  6. Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT et al. Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 2003; 167: 274–280.

    Article  CAS  Google Scholar 

  7. Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 1995; 27: 274–279.

    Article  CAS  Google Scholar 

  8. Westberg L, Bah J, Rastam M, Gillberg C, Wentz E, Melke J et al. Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology 2002; 26: 789–793.

    Article  CAS  Google Scholar 

  9. Hu X, Giotakis O, Li T, Karwautz A, Treasure J, Collier DA . Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa. Neuroreport 2003; 14: 781–783.

    Article  CAS  Google Scholar 

  10. Fehr C, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N . Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr Genet 2000; 10: 59–65.

    Article  CAS  Google Scholar 

  11. Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ . 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology (Berl) 1997; 133: 309–312.

    Article  CAS  Google Scholar 

  12. Burnet PW, Smith KA, Cowen PJ, Fairburn CG, Harrison PJ . Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder. Psychiatr Genet 1999; 9: 101–104.

    Article  CAS  Google Scholar 

  13. Lentes KU, Hinney A, Ziegler A, Rosenkranz K, Wurmser H, Barth N et al. Evaluation of a Cys23Ser mutation within the human 5-HT2C receptor gene: no evidence for an association of the mutant allele with obesity or underweight in children, adolescents and young adults. Life Sci 1997; 61: PL9–P16.

    Article  CAS  Google Scholar 

  14. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–1696.

    CAS  PubMed  Google Scholar 

  15. Reynolds GP, Zhang Z, Zhang X . Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry 2003; 160: 677–679.

    Article  Google Scholar 

  16. De Luca V, Mueller DJ, de Bartolomeis A, Kennedy JL . Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol 2007; 10: 697–704.

    Article  CAS  Google Scholar 

  17. Mulder H, Franke B, van der-Beek van der AA, Arends J, Wilmink FW, Egberts AC et al. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J 2007; 7: 318–324.

    Article  CAS  Google Scholar 

  18. Godlewska BR, Olajossy-Hilkesberger L, Ciwoniuk M, Olajossy M, Marmurowska-Michałowska H, Limon J et al. Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene. Pharmacogenomics J 2009; 9: 234–241.

    Article  CAS  Google Scholar 

  19. Pooley EC, Fairburn CG, Cooper Z, Sodhi MS, Cowen PJ, Harrison PJ . A 5-HT2C receptor promoter polymorphism (HTR2C -759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet B Neuropsychiatr Genet 2004; 126: 124–127.

    Article  Google Scholar 

  20. Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K . Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 2000; 43: 373–376.

    Article  CAS  Google Scholar 

  21. De Luca V, Müller DJ, Hwang R, Lieberman JA, Volavka J, Meltzer HY et al. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis. Hum Psychopharmacol 2007; 22: 463–467.

    Article  CAS  Google Scholar 

  22. Park YM, Cho JH, Kang SG, Choi JE, Lee SH, Kim L et al. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients. J Clin Pharm Ther 2008; 33: 55–60.

    Article  Google Scholar 

  23. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80: 95–103.

    Google Scholar 

  24. Young EH, Wareham NJ, Farooqi S, Hinney A, Hebebrand J, Scherag A et al. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes 2007; 31: 1437–1441.

    Article  CAS  Google Scholar 

  25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association (APA): Washington, DC, 1994.

  26. Surtees PG, Wainwright NWJ, Brayne C . Psychosocial etiology of chronic disease: a pragmatic approach to the assessment of lifetime affective morbidity in an EPIC component study. J Epidemiol Commun Health 2000; 54: 114–222.

    Article  CAS  Google Scholar 

  27. Ware JE, Snow KK, Kosinski M, Gandek B . SF-36 Health Survey: Manual and Interpretation Guide. Nimrod Press: Boston, 1993.

    Google Scholar 

  28. Rogers WH, Adler DA, Bungay KM, Wilson IB . Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol 2005; 58: 370–377.

    Article  Google Scholar 

  29. Eysenck SBG, Eysenck HJ, Barrett P . A revised version of the Psychoticism scale. Personality Individual Diff 1985; 6: 21–29.

    Article  Google Scholar 

  30. Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.

    Article  CAS  Google Scholar 

  31. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25–34.

    Article  CAS  Google Scholar 

  32. Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S . Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet 2005; 133: 97–100.

    Article  Google Scholar 

  33. Reynolds GP, Zhang ZJ, Zhang XB . Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002; 359: 2086–2087.

    Article  CAS  Google Scholar 

  34. de Wit LM, van Straten A, van Herten M, Penninx BW, Cuijpers P . Depression and body mass index, a u-shaped association. BMC Public Health 2009; 9: 14.

    Article  Google Scholar 

  35. Dong C, Sanchez LE, Price RA . Relationship of obesity to depression: a family-based study. Int J Obes Relat Metab Disord 2004; 28: 790–795.

    Article  CAS  Google Scholar 

  36. Berwick DM, Murphy JM, Goldman PA, Ware JE, Barsky AJ, Weinstein MC . Performance of a five-item mental health screening test. Medical Care 1991; 29: 169–176.

    Article  CAS  Google Scholar 

  37. Rumpf HM, Meyer C, Hapke U, John U . Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard. Psychiatry Res 2001; 105: 243–253.

    Article  CAS  Google Scholar 

  38. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ . A longitudinal twin study of personality and major depression in women. Arch Gen Psychiatry 1993; 50: 853–862.

    Article  CAS  Google Scholar 

  39. Gunes A, Melkersson KI, Scordo MG, Dahl ML . Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine. J Clin Psychopharmacol 2009; 29: 65–68.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the volunteers in the EPIC–Norfolk Study, who gave their time to take part in this study. We thank the participants and general practitioners who took part in this study and the staff associated with the research programme. EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883) with additional support from the European Union, Stroke Association, British Heart Foundation, Department of Health and the Wellcome Trust. We thank Jian’an Luan for his assistance in haplotype analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R J F Loos.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vimaleswaran, K., Zhao, J., Wainwright, N. et al. Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort. Int J Obes 34, 1028–1033 (2010). https://doi.org/10.1038/ijo.2009.292

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2009.292

Keywords

This article is cited by

Search

Quick links